EXELIXIS, INC. (EXEL) FY2026 Q2 P&L / Income Statement

EXELIXIS, INC. (EXEL) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-04 through 2026-07-03. View: Product and service (Net Product Revenues Disaggregated by Product). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues

628,690,000 US dollars

Cost of goods sold

20,657,000 US dollars

Gross profit (calculated)

608,033,000 US dollars

Operating expenses (calculated)

359,619,000 US dollars

Income from operations

248,414,000 US dollars

Other income (expense), net (calculated)

14,264,000 US dollars

Income before income taxes

262,678,000 US dollars

Provision for income taxes

50,628,000 US dollars

Segment and consolidated net income

212,050,000 US dollars

Cabometyx

570,648,000 US dollars

Cometriq

2,377,000 US dollars

License revenues

59,810,000 US dollars

Research and development

211,987,000 US dollars

Selling, general and administrative

147,632,000 US dollars

Revenue before reconciliation (calculated)

632,835,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.

Collaboration services revenues

negative 4,145,000 US dollars. Reported reconciliation to consolidated revenue.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.